Alimera Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021 and Provide Corporate Update
Alimera Sciences, Inc. is set to report its fourth quarter and full year 2020 financial results on February 24, 2021, after the market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alimera Sciences, Inc. is set to report its fourth quarter and full year 2020 financial results on February 24, 2021, after the market closes. A conference call will take place on February 25, 2021, at 9:00 AM ET, to discuss the financial results and corporate developments. Participants can pre-register for the call or join via dial-in options. A replay will be available for those unable to attend the live session. Alimera focuses on prescription ophthalmic pharmaceuticals for retinal diseases, addressing significant unmet medical needs.
Positive
- Upcoming financial results reporting may provide insights into business performance.
- Conference call aims to engage investors and stakeholders.
Negative
- None.
Details
News Market Reaction – ALIM
The recorded move for ALIM in the trading session of this news was +1.54%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call to be held Thursday, February 25, 2021 at 9:00am Eastern Time
ATLANTA, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, announces today that it will report fourth quarter and full year 2020 financial results on Wednesday, February 24, 2021 after the market close.
Management will host a conference call at 9:00 AM ET on Thursday, February 25, 2021 to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question and answer session.
Participants are asked to pre-register for the call.
Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-866-777-2509 (domestic) or 1-412-317-5413 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.
The conference call will also be available through a live webcast, which is also available through the company’s website.
A webcast replay of the call will be available approximately one hour after the end of the call through May 25, 2021. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code 10152084. The telephonic replay will be available until March 11, 2021.
About Alimera Sciences, Inc.
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.
| For press inquiries: | For investor inquiries: |
| Jules Abraham | Scott Gordon |
| for Alimera Sciences | for Alimera Sciences |
| 917-885-7378 | scottg@coreir.com |
| julesa@coreir.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.